RxDoctor Payments DataLook up a doctor →

Richard Glover, MD

Family Medicine · Newton, KSNPI 1063480937

Payments from drug & device makers

$19,637,066in general payments, 2019–2025

Across 4,163 payments — averaging $4717.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$11M
  • Pfizer$3.8M
  • Sanofi Pasteur Inc.$886K
  • Emergent Biosolutions Inc.$835K
  • Eli Lilly$579K
  • Janssen Research & Development, LLC$552K
  • plus $2M from 53 others
$50,298in research payments, 2019–2025

Across 10 payments — averaging $5029.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Valneva Austria GmbH$35K
  • Eli Lilly$15K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Modernatx, Inc.2,667$10,984,831
Pfizer396$3,768,417
Sanofi Pasteur Inc.45$885,676
Emergent Biosolutions Inc.14$835,026
Eli Lilly43$578,661
Janssen Research & Development, LLC18$551,908
Valneva Austria GmbH25$544,191
Amgen71$384,765
AbbVie(2 entities)265$379,283
Seqirus USA Inc33$230,104
Takeda Pharmaceuticals U.S.A., Inc.29$136,036
Bavarian Nordic A/s30$116,888
IBSA Institut Biochimique SA9$69,910
AstraZeneca27$62,002
Johnson & Johnson7$44,612
Novo Nordisk AS7$36,554
Alnylam Pharmaceuticals Inc.10$18,217
Novavax Inc1$3,592
Lilly USA, LLC133$1,392
Novo Nordisk87$904
Pacira Therapeutics, Inc.7$483
Astellas Pharma US Inc26$407
Bayer28$325
Novartis30$304
Biohaven Pharmaceutical Holding Company Ltd.17$225
Merck15$224
Paratek Pharmaceuticals, Inc.8$199
Sumitomo Pharma America, Inc.11$180
Biohaven Pharmaceuticals, Inc.9$167
Eisai Inc.8$149
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC9$147
Sunovion Pharmaceuticals Inc.10$130
Abbott7$122
Daiichi Sankyo Inc.8$121
Amarin Pharma, Inc.7$115
GSK6$107
Otsuka America Pharmaceutical, Inc.4$93
Boehringer Ingelheim5$72
Mylan Specialty L.p.4$70
Nestle Healthcare Nutrition Inc.2$45
Upsher-smith Laboratories LLC2$44
Exact Sciences3$42
Currax Pharmaceuticals LLC2$40
Cequr Corporation1$31
Ironwood Pharmaceuticals, Inc2$27
Teva Pharmaceuticals USA, Inc.2$26
E.r. Squibb & Sons, L.L.C.1$25
Cranial Technologies, Inc1$20
Esperion Therapeutics, Inc.1$20
Jazz Pharmaceuticals Inc.1$18
Kyowa Kirin, Inc.1$17
Almatica Pharma LLC1$16
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)1$16
Shire North American Group Inc1$14
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$14
Genentech USA, Inc.1$13
Sanofi-aventis U.S. LLC1$12
Echosens North America, Inc.1$10
Ultragenyx Pharmaceutical Inc.1$4

How this compares

$19,637,066 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas →

Medicare billing

Part B allowed, 2024
$163,001
Medicare patients
413
Services billed
2,084

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Newton

See the full list for Kansas →

Where these figures come from

Is this you, or does something look wrong? →